Search Results - "Cuzzoni, Eva"

Reappraisal of Antimalarials in Interferonopathies: New Perspectives for Old Drugs by Piscianz, Elisa, Cuzzoni, Eva, Sharma, Rajan, Tesser, Alessandra, Sapra, Pooja, Tommasini, Alberto

“…The story of antimalarials as antinflammatory drugs dates back several centuries. Chinin, the extract of the Cinchona bark, has been exploited since the 18th…”
Get more information

Pharmacogenetics of azathioprine in inflammatory bowel disease: A role for glutathione-S-transferase? by Stocco, Gabriele, Pelin, Marco, Franca, Raffaella, De Iudicibus, Sara, Cuzzoni, Eva, Favretto, Diego, Martelossi, Stefano, Ventura, Alessandro, Decorti, Giuliana

“…Azathioprine is a purine antimetabolite drug commonly used to treat inflammatory bowel disease(IBD).In vivo it is active after reaction with reduced…”
Get full text

Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients by Lucafò, Marianna, Granata, Simona, Bonten, Erik J., McCorkle, Robert, Stocco, Gabriele, Caletti, Chiara, Selvestrel, Davide, Cozzarolo, Alessio, Zou, Chan, Cuzzoni, Eva, Pasini, Andrea, Montini, Giovanni, Gambaro, Giovanni, Decorti, Giuliana, Evans, William, Zaza, Gianluigi

“…To assess whether NLRP3 gene promoter methylation was able to discriminate glucocorticoid (GC)‐resistant from GC‐sensitive idiopathic nephrotic syndrome (INS),…”
Get full text

Fate of lymphocytes after withdrawal of tofacitinib treatment by Piscianz, Elisa, Valencic, Erica, Cuzzoni, Eva, De Iudicibus, Sara, De Lorenzo, Elisa, Decorti, Giuliana, Tommasini, Alberto

“…Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to…”
Get full text

Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn’s disease by Taddio, Andrea, Tommasini, Alberto, Valencic, Erica, Biagi, Ettore, Decorti, Giuliana, De Iudicibus, Sara, Cuzzoni, Eva, Gaipa, Giuseppe, Badolato, Raffaela, Prandini, Alberto, Biondi, Andrea, Ventura, Alessandro

“…Mesenchymal stem cells(MSC) are cells of stromal origin which exhibit unlimited self-renewal capacity and pluripotency in vitro.It has recently been observed…”
Get full text

Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease:Effect of N-acetyl transferase polymorphisms by Stocco, Gabriele, Cuzzoni, Eva, De Iudicibus, Sara, Favretto, Diego, Malusà, Noelia, Martelossi, Stefano, Pozzi, Elena, Lionetti, Paolo, Ventura, Alessandro, Decorti, Giuliana

“…AIM: To evaluate variation of the concentration of thiopurine metabolites after 5-aminosalicylate(5-ASA) interruption and the role of genetic polymorphisms of…”
Get full text

Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study by Naviglio, Samuele, Lacorte, Doriana, Lucafò, Marianna, Cifù, Adriana, Favretto, Diego, Cuzzoni, Eva, Silvestri, Tania, Pozzi Mucelli, Martina, Radillo, Oriano, Decorti, Giuliana, Fabris, Martina, Bramuzzo, Matteo, Taddio, Andrea, Stocco, Gabriele, Alvisi, Patrizia, Ventura, Alessandro, Martelossi, Stefano

“…OBJECTIVES:Anti-tumor necrosis factor antibodies have led to a revolution in the treatment of inflammatory bowel diseases (IBD); however, a sizable proportion…”
Get full text

MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome by Cuzzoni, Eva, Franca, Raffaella, De Iudicibus, Sara, Marcuzzi, Annalisa, Lucafò, Marianna, Pelin, Marco, Favretto, Diego, Monti, Elena, Morello, William, Ghio, Luciana, La Scola, Claudio, Mencarelli, Francesca, Pasini, Andrea, Montini, Giovanni, Decorti, Giuliana, Stocco, Gabriele

“…Purpose Idiopathic nephrotic syndrome (INS) is the most frequent form of childhood nephrotic syndrome. Steroids represent the best therapeutic option; however,…”
Get full text

Association between BclI polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone by Cuzzoni, Eva, De Iudicibus, Sara, Bartoli, Fiora, Ventura, Alessandro, Decorti, Giuliana

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • In vitro lymphocyte steroid sensitivity has been suggested as a useful tool to predict in vivo response to…”
Get full text

Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease by Stocco, Gabriele, Martelossi, Stefano, Arrigo, Serena, Barabino, Arrigo, Aloi, Marina, Martinelli, Massimo, Miele, Erasmo, Knafelz, Daniela, Romano, Claudio, Naviglio, Samuele, Favretto, Diego, Cuzzoni, Eva, Franca, Raffaella, Decorti, Giuliana, Ventura, Alessandro

“…Early-onset inflammatory bowel disease (IBD) is generally aggressive, with a high probability of complications and need of surgery. Despite the introduction of…”
Get full text

Deletion of Glutathione-S-Transferase M1 Reduces Azathioprine Metabolite Concentrations in Young Patients With Inflammatory Bowel Disease by Stocco, Gabriele, Cuzzoni, Eva, De Iudicibus, Sara, Franca, Raffaella, Favretto, Diego, Malusà, Noelia, Londero, Margherita, Cont, Gabriele, Bartoli, Fiora, Martelossi, Stefano, Ventura, Alessandro, Decorti, Giuliana

“…GOALS:To investigate, in young patients with inflammatory bowel disease (IBD) treated with azathioprine, the association between genetic polymorphisms of…”
Get full text

Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab by Naviglio, Samuele, Lacorte, Doriana, Lucafò, Marianna, Cifù, Adriana, Favretto, Diego, Cuzzoni, Eva, Silvestri, Tania, Pozzi Mucelli, Martina, Radillo, Oriano, Decorti, Giuliana, Fabris, Martina, Bramuzzo, Matteo, Taddio, Andrea, Stocco, Gabriele, Alvisi, Patrizia, Ventura, Alessandro, Martelossi, Stefano

“…ABSTRACT Objectives: Anti‐tumor necrosis factor antibodies have led to a revolution in the treatment of inflammatory bowel diseases (IBD); however, a sizable…”
Get full text

Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome by Cuzzoni, Eva, De Iudicibus, Sara, Franca, Raffaella, Stocco, Gabriele, Lucafò, Marianna, Pelin, Marco, Favretto, Diego, Pasini, Andrea, Montini, Giovanni, Decorti, Giuliana

“…Idiopathic nephrotic syndrome represents the most common type of primary glomerular disease in children: glucocorticoids (GCs) are the first-line therapy, even…”
Get full text

SXR rs3842689: a prognostic factor for steroid sensitivity or resistance in pediatric idiopathic nephrotic syndrome by Turolo, Stefano, Edefonti, Alberto, Lepore, Marta, Ghio, Luciana, Cuzzoni, Eva, Decorti, Giuliana, Pasini, Andrea, Materassi, Marco, Malaventura, Cristina, Pugliese, Fabrizio, Montini, Giovanni

“…of the study was to analyse the impact of SXR rs3842689 polymorphism on the response to corticosteroids in pediatric idiopathic nephrotic syndrome. 66 children…”
Get full text

Azathioprine pharmacokinetics in early onset inflammatory bowel disease by Stocco, Gabriele, Martelossi, Stefano, De Iudicibus, Sara, Favretto, Diego, Cuzzoni, Eva, Franca, Raffaella, Decorti, Giuliana, Ventura, Alessandro

Get full text

Association between Bcl I polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone by Cuzzoni, Eva, De Iudicibus, Sara, Bartoli, Fiora, Ventura, Alessandro, Decorti, Giuliana

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT •  In vitro lymphocyte steroid sensitivity has been suggested as a useful tool to predict in vivo response to…”
Get full text

Differential action of 3-hydroxyanthranilic acid on viability and activation of stimulated lymphocytes by Piscianz, Elisa, Cuzzoni, Eva, De Iudicibus, Sara, Valencic, Erica, Decorti, Giuliana, Tommasini, Alberto

“…Lymphocytes proliferation after antigen-driven activation leads to an increase in cell count, which could last some week, until apoptosis mechanisms allow the…”
Get full text

Association between Bc/l polymorphism in the NR3C1 gene and in vitro individual variations in lymphocyte responses to methylprednisolone by CUZZONI, Eva, DE LUDICIBUS, Sara, BARTOLI, Fiora, VENTURA, Alessandro, DECORTI, Giuliana

Get full text

Fate of Lymphocytes after Withdrawal of Tofacitinib Treatment: e85463 by Piscianz, Elisa, Valencic, Erica, Cuzzoni, Eva, Iudicibus, Sara De, Lorenzo, Elisa De, Decorti, Giuliana, Tommasini, Alberto

“…Tofacitinib (Tofa) is an inhibitor of Janus Kinase 3, developed for the treatment of autoimmune diseases and for the prevention of transplant rejection. Due to…”
Get full text